In order to explore the clinical relevance of SLC2A1 expression in colon cancer, clinical data from TCGA were downloaded for analysis and SLC2A1 was found to have high predictive power for the variable SLC2A1 in predicting the outcomes of Normal and Tumor (AUC = 0.968, CI = 0.957–0.979, Figure 2(d)). The gene discussed is SLC2A1; the disease is colonic neoplasm.